Try our Advanced Search for more refined results
Intellectual Property UK
-
March 12, 2025
Florist Says Ex-CEO Diverted Cash Amid False Fraud Claim
A high-end London florist has sued its former CEO for an estimated £4.1 million ($5.3 million) alleging the businessman diverted its revenue before falsely telling customers that the business was insolvent and committing fraud.
-
March 12, 2025
'Shorts' TM Too Descriptive Of Short Films For EU Mark
A European Union court has refused to revive an attempt by a film distributor to get a "Shorts" trademark over short films, ruling on Wednesday that the brand is too descriptive to function as a trademark.
-
March 11, 2025
Fire-Proof Fabric Maker Sues To Nix Rival's Fire Barrier Patent
A manufacturer of fire-resistant construction materials told a London patent court that a patent owned by its competitor contains features that were already industry-standard, whilst also claiming that its rival had threatened the manufacturer's clients for using its products.
-
March 11, 2025
Appeals Justices' Latest FRAND Split Poised For Top Court
The Court of Appeal's split judgment blocking Tesla from litigating licensing terms for a full wireless patent portfolio against the pool manager presents a prime opportunity for the U.K.'s top court to further clarify the country's jurisdiction to settle licensing spats over standard-essential patents, experts say.
-
March 11, 2025
Frasers Group Unit Beats Insect Protein Co. 'Wriggle' TM
A Frasers Group unit has convinced British officials that a company manufacturing cricket-based meat shouldn't be able to sell any products under the "Wriggle" brand, because shoppers might mix it up with its existing Wiggle mark.
-
March 11, 2025
Motorola, Ericsson License Terms Clarified Ahead Of Trial
A London court on Tuesday marked the boundaries of Motorola's 2011 license to use Ericsson's cellular technology, helping set the stage for the Swedish company's FRAND showdown with the Lenovo group later in the year.
-
March 11, 2025
Roche Gets Illumina Unit's DNA Testing Patent Revoked
Roche has persuaded a European appeals panel to revoke an Illumina Inc. subsidiary's patent over a way of detecting fetal DNA in maternal blood, proving that the technique isn't inventive.
-
March 10, 2025
UPC Nixes Tridonic's Infringement Case Over Boost Converter
Europe's patent court has sided with Cupower in a dispute over a circuit that improves power use in electrical devices, ruling that its technology didn't incorporate a key feature from Tridonic's patent.
-
March 10, 2025
Kenwood Chef Maker Loses Challenge To 'Misterchef' TM
DeLonghi, which owns kitchen appliance brand Kenwood, has failed to convince trademark officials that a rival's "Misterchef" mark would piggyback off of Kenwood's prestige, with officials finding that shoppers wouldn't mistake it for a Kenwood creation.
-
March 10, 2025
IBM Wins Software Reverse Engineering Claim Against Rival
A London judge ruled Monday that a tech firm breached its customer agreement with IBM by reverse engineering the computing giant's software to help develop a competing product.
-
March 10, 2025
AstraZeneca's $1B Drug Protections Too Vague, Generics Say
Generic drugmakers urged the High Court to revoke patent protections for AstraZeneca's $1 billion Type-2 diabetes treatment Forxiga at the start of invalidity proceedings on Monday as the pharmaceutical companies hope to clear the way to launch their competitor medicines.
-
March 10, 2025
Harvard, MIT Relinquish CRISPR Gene Editing Patent
The Broad Institute and a trio of U.S. universities have given up one of their jointly owned gene editing patents after a European appeals panel warned that it would likely invalidate the patent.
-
March 07, 2025
Chinese Medical Co.'s Suction Device Patent Claim Backfires
A Chinese medical device maker on Friday failed to convince a London court that a British rival infringed its patent for a suction device to remove kidney stones because the patented technology found in its rival's products was standard practice.
-
March 07, 2025
UK Litigation Roundup: Here's What You Missed In London
This past week in London has seen an Iranian oil company sued for $95 million, Betfred hit with a lawsuit from a property company and NHS England face a human rights claim brought by a man detained under the Mental Health Act for over 20 years. Here, Law360 looks at these and other new claims in the U.K.
-
March 07, 2025
Flower Biz Hits Back At Rival In Google Search TM Fight
A fresh flower retailer has denied infringing a rival's trademarks by using its name as a keyword for Google ads, telling a London court that it has stuck to a longstanding agreement not to do so.
-
March 07, 2025
EU Court Rules Against Forced Transfer Of Musician Rights
The National Orchestra of Belgium cannot force its musicians to transfer their intellectual property rights to their employer without consent, the European Union's top court ruled, in a move that offers stronger protections for performers in the digital and live-performance sectors.
-
March 07, 2025
EasyGroup Beats Challenge To 'EasyCasa' TM
European officials have given easyGroup the greenlight to market furniture and household goods under the "easyCasa" trademark, after ruling that a Turkish lifestyle brand had failed to show it had genuinely used the "Casa" name in Western Europe.
-
March 07, 2025
Toy Maker Drops EU Trademark Appeal Over Rubik's Cube
A toy company has ended its appeal against a decision to shun its bid for a trademark in the European Union covering a 3D picture that resembles a Rubik's Cube.
-
March 06, 2025
Don't Give Teva 'Eighth Bite' At $235M Patent Trial, GSK Says
GlaxoSmithKline has told a Delaware federal judge that Teva's request for a new trial in the drugmakers' decade-long, $235 million "skinny label" patent fight over heart failure medication is an "eighth bite at the same apple."
-
March 06, 2025
Visual Variations Argued As Key In 'Lego Exception' Designs
Courts should look at the "overall impression" that a connector makes in the context of a broader modular system in order to decide whether the design merits intellectual property protections, an adviser to the European Union's highest court said Thursday in a case that could affect how something called the "Lego exception" applies.
-
March 06, 2025
Ericsson Can't Take Lenovo License Feud To Top UK Court
A London appeals court has refused Ericsson's bid to have the U.K.'s top court consider its ongoing licensing feud with Lenovo after ruling that a "willing licensor" in the Swedish company's position would have agreed to an interim license.
-
March 06, 2025
Stoma Bag Maker Beats Rival's Patent Infringement Case
A medical device maker can continue selling a stoma bag that collects waste from people with diverted colons, after convincing a London judge that it wasn't infringing a rival's patent that reduced bulging.
-
March 06, 2025
Tesla Fails To Revive 5G FRAND Feud With Avanci, InterDigital
A London appeals court refused on Thursday to restart Tesla's attempt to sue Avanci and InterDigital in the U.K. over licensing rates for a 5G patent pool, drawing a boundary on its jurisdiction over such disputes.
-
March 06, 2025
Crocs Can't Block Rival's Moccasin-Like EU Shoe Design
European officials have rejected Crocs' challenge to a rival's shoe design, ruling that just because it shared features with boat shoes or stitched Moccasins didn't mean shoppers wouldn't notice it was a sportier aesthetic.
-
March 05, 2025
Enedo Loses Appeal For TM Over Similarity With Enedis
A European court has dismissed a bid from Finnish electrics manufacturer Enedo to reinstate a trademark application for "Enedo: Reshaping Electricity," with the court holding that the name clashes with a rival's branding.
Expert Analysis
-
Effective IP Enforcement Is Taking Shape In China
As the Chinese economy grows and becomes more intertwined with other world economies, non-Chinese intellectual property rights holders in the energy sector must understand new enforcement mechanisms under the National Intellectual Property Rights Strategy Action Plan to maintain a competitive IP strategy, say Brad Chin and Kevin Tamm of Bracewell & Giuliani LLP.
-
Privacy, Security, Risk: What You Missed At IAPP Conference
A few weeks ago, privacy and security professionals from around the globe gathered for the second joint conference between the International Association of Privacy Professionals and the Cloud Security Alliance Congress. Aravind Swaminathan, Antony Kim and Emily Tabatabai of Orrick Herrington & Sutcliffe LLP offer seven key takeaways.
-
Approach To '2nd Medical Use' Claims Varies Across EU
A number of recent court decisions have highlighted important gaps and a lack of consensus between key EU member states on the law regarding infringement of second medical use patents. The rulings also demonstrate how differences in the drug dispensing and reimbursement systems between different EU countries can influence the nature of the relief available, say attorneys with Jones Day.
-
5 Ways University Students, Faculty Risk Forfeiting IP Rights
Although academic institutions recognize the value of translating research into patents, licenses and commercial products, there remains a strong scholastic motivation for faculty and students to publish their research findings in journals and at academic conferences to advance their reputation and career. As a result, intellectual property is often an afterthought, say attorneys with Meunier Carlin & Curfman LLC.
-
EPO Set To Clarify Priority And Divisional Application Problem
In a recent decision, one European Patent Office Board of Appeal finally decided that the question of the possibility of poisonous priority and divisional applications should be settled once and for all. The Enlarged Board of Appeal may simply do away with poisonous applications or possibly formulate detailed criteria for the assessment of partial priority, say attorneys with CH KILGER Anwaltspartnerschaft mbB.
-
EU High Court Sets Important SEP Precedent
The EU high court's recent ruling in Huawei Technologies Co. Ltd. v. ZTE Corp. provided a significant amount of guidance on standard-essential patents, injunctions and abuse of dominance but addresses only some of the legal questions that SEP holders and alleged infringers face in these situations, and even the questions addressed are in part expressed in very broad terms inviting different interpretations, say Axel Gutermuth and Christopher Stothers of Arnold & Porter LLP.
-
Procuring Personalized Medicine Patents In US Vs. Europe
In the United States, many patent claims related to personalized medicine are being challenged based on patentable subject matter, whereas in Europe, most claims are questioned based on novelty and inventive step, says Gabriela Coman of Dickstein Shapiro LLP.
-
Rival Global Views On Patent Disclosures
When it comes to patent disclosure requirements, terminology varies widely across the world. But the major national patent players seem to break down into two chief opposing views on just how much support patent claims and amendments require in originally filed applications, says Stephen Keefe of Rabin & Berdo PC.
-
Use Strategic Continuation Practice To Monetize IP
Continuation patent applications provide a useful mechanism to raise the overall quality of patents within a given portfolio, says Michael Moore, intellectual property and deputy general counsel at Rambus Inc.
-
Using Patents To Curtail Climate Change: A Proposal
Last fall, 74 countries and more than 1,000 businesses signed a declaration calling on all nations to price carbon dioxide and other greenhouse gases, yet the prospects of meaningful government action are dim. We see a possible solution in our patent system — impose a flexible license fee tied to greenhouse gas emissions, say attorneys with Klarquist Sparkman LLP, Green Patent Law, Robins Kaplan LLP, Burns & Levinson LLP and Susman Godfrey LLP.
-
22 Ways Congress Can Save Section 101
As delightful as the post-Alice patent-invalidating trend may be to patent defendants, it has created enormous consequences for companies that rely on patent protection to protect crucial technology assets, including the loss of business contracts, disrupted partnerships and increased difficulty in obtaining venture funding. It is time for Congress to act, says Robert Sachs of Fenwick & West LLP.
-
Top 5 IPR Discovery Tips For Patent Owners
Recent Patent Trial and Appeal Board orders shed some light on how parties can use the inter partes review discovery periods to their best advantage, says Carly Levin of Venable LLP.
-
What To Know About Extending Patent Term In Southeast Asia
For pharmaceutical products, the most general form of extended patent protection available in Southeast Asia is currently data exclusivity, says James Kinnaird of Marks & Clerk.
-
New Guidelines Suggest A Friendlier European Patent Office
While many of the changes in the latest European Patent Office guidelines reflect the current practice of the EPO’s boards of appeal, they also suggest that the first-instance departments of the EPO may be moving toward a less rigid and formalistic approach to some issues, say Philip Cupitt and Hazel Ford of Finnegan Henderson Farabow Garrett & Dunner LLP.
-
Why Canada's Patent Prosecution Highway Is A Huge Success
Canada's Patent Prosecution Highway program has positioned the country as a highly cost-effective jurisdiction in which to procure patent protection with exceptional speed and efficacy, says Elliott Simcoe of Smart & Biggar.